Treatment with polychemotherapy
was initiated after concluding that the patient had an unresectable cancer.
 70/M + -- *At PTCL-NOS diagnosis; LN: lymph node; BM: bone marrow; PCT: polychemotherapy
; RT: radiotherapy; IL-4: interleukin 4; NA: not available; ND: not done; PTCL-NOS: peripheral T-cell lymphoma not otherwise specified; CLL/SLL: chronic lymphocytic leukemia/small lymphocytic lymphoma; TIA1: T-cell intracellular antigen-1.
Gisslinger, "Marked and sustained improvement of systemic sclerosis following polychemotherapy
for coexistent multiple myeloma," Clinical and Experimental Rheumatology, vol.
This suggests the need for an early diagnosis when the patient's performance status still permits the administration of polychemotherapy
regimens burdened by great toxicity.
Although modern polychemotherapy
has significantly improved Hodgkin lymphoma (HL) survival rates, relapsed and refractory HL have still poor prognosis .
Steck, "Eclampsia after polychemotherapy
for nodal-positive breast cancer during pregnancy," European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.
Patient treatment cards of all patients on polychemotherapy
(PCT) who started treatment between 01.01.2013 and 31.12.2014 were studied.
Peto R, Davies C, Godwin J, et al.: Comparisons between different polychemotherapy
regimens for early breast cancer: meta-analyses of longterm outcome among 100,000 women in 123 randomised trials.
The first group of premenarchal patients aged from 3 to 7.5 years undergoing polychemotherapy
without GnRH analogs; the age of the second group of postmenarche women who received GnRH analogs before polychemotherapy
was 14.7-20 years; the third group were postmenarchal patients aged 15.9 to 20 years who received polychemotherapy
without GnRH analog.
Multifocal osteonecrosis in children and adolescents after polychemotherapy
. Z Orthop Ihre Grenzgeb.
Complete hematologic remission and efficiency of fluid depletion therapy allowed the second course of polychemotherapy
after which the patient developed an acute hepatitis C.
Transurethral resection  of bladder tumour (Burkitt's lymphoma) plus subsequent antiretroviral treatment with stavudine (40 mg twice daily), lamivudine (150 mg twice daily), and nelfinavir (750 mg 3 8 months of times daily), as well followup as antitumour polychemotherapy
(4 cycles of cyclophosphamide, vincristine, doxorubicin, and dexamethasone, alternated with 4 cycles of methotrexate and cytarabine) Tsiriopoulos Cystectomy and ileal Details are not et al.